Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Placebo-controlled Evaluation of the Safety and Efficacy of Terbogrel in Patients With Primary Pulmonary Hypertension
Conditions
Interventions
Terbogrel low dose
Terbogrel high dose
+1 more
Start Date
May 1, 1998
Primary Completion Date
September 1, 1999
Last Updated
August 22, 2014
NCT07079592
NCT05719415
NCT07039604
NCT03388476
NCT01065454
NCT04732221
Lead Sponsor
Boehringer Ingelheim
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions